bisacodyl has been researched along with Lupus Erythematosus, Systemic in 1 studies
Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsieh, JF | 1 |
| Que, J | 1 |
| Tsai, SC | 1 |
| Cheng, KY | 1 |
| Lin, WY | 1 |
| Wang, SJ | 1 |
1 trial available for bisacodyl and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Does bowel preparation improve the quality of abdominal gallium scintigraphy?
Topics: Abdomen; Adult; Bisacodyl; Castor Oil; Cathartics; Female; Gallium; Gallium Radioisotopes; Humans; K | 2000 |